These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10749459)

  • 1. Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a developing country.
    Sáez-Llorens X; Castrejón de Wong MM; Castaño E; De Suman O; De Morös D; De Atencio I
    Pediatr Infect Dis J; 2000 Mar; 19(3):200-6. PubMed ID: 10749459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a "handshake" stewardship program versus a formulary restriction policy on High-End antibiotic use, expenditure, antibiotic resistance, and patient outcome.
    Moghnieh R; Awad L; Abdallah D; Jadayel M; Sinno L; Tamim H; Jisr T; El-Hassan S; Lakkis R; Dabbagh R; Bizri AR
    J Chemother; 2020 Nov; 32(7):368-384. PubMed ID: 32364030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in antibiotic use, cost and consumption after an antibiotic restriction policy applied by infectious disease specialists.
    Ozkurt Z; Erol S; Kadanali A; Ertek M; Ozden K; Tasyaran MA
    Jpn J Infect Dis; 2005 Dec; 58(6):338-43. PubMed ID: 16377863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram.
    Cook PP; Catrou PG; Christie JD; Young PD; Polk RE
    J Antimicrob Chemother; 2004 May; 53(5):853-9. PubMed ID: 15044426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program.
    Frank MO; Batteiger BE; Sorensen SJ; Hartstein AI; Carr JA; McComb JS; Clark CD; Abel SR; Mikuta JM; Jones RB
    Clin Perform Qual Health Care; 1997; 5(4):180-8. PubMed ID: 10176026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of antibiotic restriction on broad spectrum antibiotic usage in the ICU of a developing country.
    Siddiqui S; Hussein K; Manasia R; Samad A; Salahuddin N; Zafar A; Hoda MQ
    J Pak Med Assoc; 2007 Oct; 57(10):484-7. PubMed ID: 17990421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a multidisciplinary approach on antibiotic consumption, cost and microbial resistance in a Czech hospital.
    Mach R; Vlcek J; Prusova M; Batka P; Rysavy V; Kubena A
    Pharm World Sci; 2007 Oct; 29(5):565-72. PubMed ID: 17610145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Direct cost of antibiotic therapy prescribed for nosocomial bacteremia. Prospective study during 6 months at a CHU (University Hospital Center)].
    Daumal F; Etienne C; Votte P; Bou P; Canarelli B; Desablens F; Schmit JL; Eb F
    Pathol Biol (Paris); 1998 Jun; 46(6):470-5. PubMed ID: 9769884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey.
    Astagneau P; Fleury L; Leroy S; Lucet JC; Golliot F; Régnier B; Brücker G
    J Hosp Infect; 1999 Aug; 42(4):303-12. PubMed ID: 10467544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
    Nikodemski T
    Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial expenditures and usage at four university hospitals. Baden-Württemberg Interuniversity Study Group.
    Kern WV; Rose AD; Hay B; Muche R; Frank U
    Infection; 2001; 29(3):127-37. PubMed ID: 11440382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes.
    White AC; Atmar RL; Wilson J; Cate TR; Stager CE; Greenberg SB
    Clin Infect Dis; 1997 Aug; 25(2):230-9. PubMed ID: 9332517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative bacteria.
    Antoniadou A; Kanellakopoulou K; Kanellopoulou M; Polemis M; Koratzanis G; Papademetriou E; Poulakou G; Giannitsioti E; Souli M; Vatopoulos A; Giamarellou H
    Scand J Infect Dis; 2013 Jun; 45(6):438-45. PubMed ID: 23336730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison.
    Lai CC; Shi ZY; Chen YH; Wang FD
    J Microbiol Immunol Infect; 2016 Feb; 49(1):74-82. PubMed ID: 26586483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs.
    Geissler A; Gerbeaux P; Granier I; Blanc P; Facon K; Durand-Gasselin J
    Intensive Care Med; 2003 Jan; 29(1):49-54. PubMed ID: 12528022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.
    Lee NY; Lee HC; Ko NY; Chang CM; Shih HI; Wu CJ; Ko WC
    Infect Control Hosp Epidemiol; 2007 Jun; 28(6):713-9. PubMed ID: 17520546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic burden of antimicrobial resistance.
    Maragakis LL; Perencevich EN; Cosgrove SE
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):751-63. PubMed ID: 18847410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.